Evidence map›Paper›PMID 34942111›Full record

ArticleAmerican journal of ophthalmology2022

Ganglion Cell Complex: The Optimal Measure for Detection of Structural Progression in the Macula.

Vahid Mohammadzadeh, Erica Su, Alessandro Rabiolo, Lynn Shi, Sepideh Heydar Zadeh, Simon K Law, Anne L Coleman, Joseph Caprioli, Robert E Weiss, Kouros Nouri-Mahdavi

Abstract read
In one paragraph

Article in American journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Sectoral analysis of macular inner retinal layers and diagnostic performance in early pseudoexfoliation glaucoma.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vahid MohammadzadehFrom the Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine (V.M., L.S., S.H.Z., S.K.L., A.L.C., J.C., K.N.M.).
Erica SuDepartment of Biostatistics, Fielding School of Public Health (E.S., R.E.W.).
Alessandro RabioloUniversity of California-Los Angeles, Los Angeles, California and; Department of Ophthalmology, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK (A.R.).
Lynn ShiFrom the Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine (V.M., L.S., S.H.Z., S.K.L., A.L.C., J.C., K.N.M.).
Sepideh Heydar ZadehFrom the Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine (V.M., L.S., S.H.Z., S.K.L., A.L.C., J.C., K.N.M.).
Simon K LawFrom the Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine (V.M., L.S., S.H.Z., S.K.L., A.L.C., J.C., K.N.M.).
Anne L ColemanFrom the Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine (V.M., L.S., S.H.Z., S.K.L., A.L.C., J.C., K.N.M.).
Joseph CaprioliFrom the Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine (V.M., L.S., S.H.Z., S.K.L., A.L.C., J.C., K.N.M.).
Robert E WeissDepartment of Biostatistics, Fielding School of Public Health (E.S., R.E.W.).
Kouros Nouri-MahdaviFrom the Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine (V.M., L.S., S.H.Z., S.K.L., A.L.C., J.C., K.N.M.). Electronic address: nouri-mahdavi@jsei.ucla.edu.

Funding

Detection of Disease Progression in Advanced GlaucomaR01EY029792 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NOURI-MAHDAVI, KOUROS · 2020 to 2024
$1.9M
NEI NIH HHS R01 EY029792
6 · The paper itself

Abstract

purposeTo test the hypothesis that macular ganglion cell complex (GCC) thickness from optical coherence tomography (OCT) provides a stronger change signal regardless of glaucoma severity compared with other macular measures.

designProspective cohort study.

methodsEyes were from 112 patients with moderate to severe glaucoma at baseline from a tertiary glaucoma center. In each 3° × 3° macular superpixel, a hierarchical Bayesian random intercept and slope model with random residual variance was fit to longitudinal full macular thickness (FMT), outer retina layers, GCC, ganglion cell-inner plexiform layer (GCIPL), and ganglion cell layer (GCL) measurements. We estimated population- and individual-level slopes and intercepts. Proportions of substantial worsening and improving superpixel slopes were compared between layers and in superpixels with mild to moderate vs severe damage (total deviation of corresponding visual field location ≥ -8 vs < -8 dB).

resultsMean (SD) follow-up time and baseline 10-2 visual field mean deviation were 3.6 (0.4) years and -8.9 (5.9) dB, respectively. FMT displayed the highest proportion of significant negative slopes (1932/3519 [54.9%]), followed by GCC (1286/3519 [36.5%]), outer retina layers (1254/3519 [35.6%]), (GCIPL) (1075/3518 [30.6%]), and (GCL) (698/3518 [19.8%]). Inner macular measures detected less worsening in the severe glaucoma group; yet GCC (223/985 [22.6%]) identified the highest proportion (GCIPL: 183/985 [18.6%]; GCL: 106/985 [10.8%]). Proportions of positive rates were small and comparable among all measures.

conclusionsGCC is the optimal macular measure for detection of structural change in eyes with moderate to severe glaucoma. Although a higher proportion of worsening superpixels was observed for FMT, a large portion of FMT change could be attributed to changes in outer retina layers.

Indexed as

GlaucomaMacula LuteaBayes TheoremHumansIntraocular PressureProspective StudiesRetinal Ganglion CellsTomography, Optical Coherence

Identifiers

PMID34942111
PMCPMC9035060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.